[go: up one dir, main page]

TN2013000507A1 - Anti-cxcr4 antibody with effector functions and its use for the treatment of cancer. - Google Patents

Anti-cxcr4 antibody with effector functions and its use for the treatment of cancer.

Info

Publication number
TN2013000507A1
TN2013000507A1 TNP2013000507A TN2013000507A TN2013000507A1 TN 2013000507 A1 TN2013000507 A1 TN 2013000507A1 TN P2013000507 A TNP2013000507 A TN P2013000507A TN 2013000507 A TN2013000507 A TN 2013000507A TN 2013000507 A1 TN2013000507 A1 TN 2013000507A1
Authority
TN
Tunisia
Prior art keywords
cancer
treatment
effector functions
cxcr4 antibody
cxcr4
Prior art date
Application number
TNP2013000507A
Other languages
English (en)
Inventor
Christine Klinguer-Hamour
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2012/061893 external-priority patent/WO2012175576A1/fr
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of TN2013000507A1 publication Critical patent/TN2013000507A1/fr

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
TNP2013000507A 2011-06-20 2013-12-05 Anti-cxcr4 antibody with effector functions and its use for the treatment of cancer. TN2013000507A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161499004P 2011-06-20 2011-06-20
PCT/EP2012/061893 WO2012175576A1 (fr) 2011-06-20 2012-06-20 Anticorps anti-cxcr4 ayant des fonctions effectrices et son utilisation pour le traitement du cancer

Publications (1)

Publication Number Publication Date
TN2013000507A1 true TN2013000507A1 (en) 2015-03-30

Family

ID=54359616

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000507A TN2013000507A1 (en) 2011-06-20 2013-12-05 Anti-cxcr4 antibody with effector functions and its use for the treatment of cancer.

Country Status (1)

Country Link
TN (1) TN2013000507A1 (fr)

Similar Documents

Publication Publication Date Title
AU2012335543A8 (en) HER3 antibodies and uses thereof
MX2021002728A (es) Combinacion de anticuerpos anti-gen 3 de la activacion del linfoncito (lag-3) y anticuerpos anti-muerte celular programada 1 (pd-1) para usarse en el tratamiento de tumores.
CA3019531A1 (fr) Combinaisons d'anticorps anti-4-1bb et d'anticorps induisant une cytotoxicite a mediation cellulaire dependante d'un anticorps (adcc) pour le traitement du cancer
SG194701A1 (en) Anti-cd40 antibodies and methods of use
EA201491011A1 (ru) Способы лечения с помощью ингибитора гамма-интерферона
TN2015000050A1 (en) Methods of treating a tauopathy
MX357965B (es) Composicion farmaceutica para el tratamiento y/o prevencion de cancer de vesicula biliar.
NZ707086A (en) Anti-cd40 antibodies and methods of use
MY196418A (en) Therapeutically Active Compounds and Their Methods of use
MX347020B (es) Anticuerpo contra el csf-1r.
EA201200998A1 (ru) Способы лечения рака поджелудочной железы
MX359794B (es) Anticuerpos anti-hepcidina y usos de los mismos.
PH12014500904B1 (en) Antibody formulations and methods
NZ631197A (en) Anti sez6 antibodies and methods of use
UA106890C2 (uk) Гуманізоване антитіло до cdcp1
EA201591786A1 (ru) Монотерапия gla для применения в лечении рака
BR112013032456A2 (pt) anticorpo anti-cxcr4 com funções efetuadoras e seu uso para o tratamento de câncer
GEP201706612B (en) Methods for the treatment of breast cancer
NZ611785A (en) Anti-notch1 antibodies
MX2019015604A (es) Anticuerpos anti-tau y usos de los mismos en el tratamiento de una tauopatia.
EA202091676A1 (ru) Способ лечения потери костной массы альвеолярного отростка посредством применения антител к склеростину
GB201109238D0 (en) Antibodies
PH12014501543A1 (en) Combination therapy for the treatment of ovarian cancer
MX2013010050A (es) Inhibidor de proteasoma delanzomib para uso en el tratamiento de lupus.
MX2013009529A (es) Tratamiento de enfermedad de crohn con fistulas.